Table 9.

GO and KEGG enrichment results for the 29 predicted and anticorrelated mRNAs targets of five miRNAs differentially expressed in the chronic period

GO termsTerm descriptionGO IDSize of termmiRNA targetExpectedEnrichment ratioRaw p valueFDR
Biological processNegative regulation of DC differentiationGO:2001198C = 2O = 2E = 0R = 576.792.88E-060.0005
Biological processRegulation of DC differentiationGO:2001199C = 2O = 2E = 0R = 576.792.88E-060.0005
Biological processDC differentiationGO:0097028C = 13O = 2E = 0.02R = 88.740.00020.0178
Biological processGlial cell developmentGO:0021782C = 69O = 3E = 0.12R = 25.080.00020.0178
Biological processRegulation of glial cell proliferationGO:0060251C = 16O = 2E = 0.03R = 72.100.00030.0214
Biological processGlial cell proliferationGO:0014009C = 23O = 2E = 0.04R = 50.160.00070.0356
Biological processRegulation of immune system processGO:0002682C = 653O = 6E = 1.13R = 5.300.00070.0356
Biological processResponse to woundingGO:0009611C = 692O = 6E = 1.20R = 50.00090.0401
Biological processNegative regulation of DNA bindingGO:0043392C = 31O = 2E = 0.05R = 37.210.00130.0498
Biological processOligodendrocyte developmentGO:0014003C = 32O = 2E = 0.06R = 36.050.00140.0498
KEGG pathwayHematopoietic cell lineageC = 124O = 3E = 0.07R = 40.295.70E-050.001
KEGG pathwayLysosomeC = 79O = 2E = 0.05R = 42.160.0010.0015